Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Millar

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Retinal Cases & Brief Reports|November 13, 2014
Malignant optic glioma presenting as an acute anterior optic neuropathyChandra Balachandran, Michael James Millar, Rajmohan Murali, et al.
ANZ Journal of Surgery|July 14, 2017
Gender, ethnicity and smoking affect pain and function in patients with rotator cuff tearsAnthony Maher, Warren Leigh, Matt Brick, et al.
Cellular Immunology|March 4, 2008
The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vectorJames Millar, Dilan Dissanayake, Teng Chih Yang, et al.
Vaccine|October 21, 2006
Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgeneXizhong Zhang, Maziar Divangahi, Patricia Ngai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunityTeng-Chih Yang, James Millar, Timothy Groves, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2005
Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopeniaNatalie Grinshtein, Teng-Chih Yang, Robin Parsons, et al.
Current Gene Therapy|October 28, 2005
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccinesZhou Xing, Michael Santosuosso, Sarah McCormick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccinesTeng Chih Yang, James Millar, Timothy Groves, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Retinal Cases & Brief Reports|November 13, 2014
Malignant optic glioma presenting as an acute anterior optic neuropathyChandra Balachandran, Michael James Millar, Rajmohan Murali, et al.
ANZ Journal of Surgery|July 14, 2017
Gender, ethnicity and smoking affect pain and function in patients with rotator cuff tearsAnthony Maher, Warren Leigh, Matt Brick, et al.
Cellular Immunology|March 4, 2008
The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vectorJames Millar, Dilan Dissanayake, Teng Chih Yang, et al.
Vaccine|October 21, 2006
Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgeneXizhong Zhang, Maziar Divangahi, Patricia Ngai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunityTeng-Chih Yang, James Millar, Timothy Groves, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2005
Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopeniaNatalie Grinshtein, Teng-Chih Yang, Robin Parsons, et al.
Current Gene Therapy|October 28, 2005
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccinesZhou Xing, Michael Santosuosso, Sarah McCormick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccinesTeng Chih Yang, James Millar, Timothy Groves, et al.
Pageof 2